KARYOPHARM THERAPEUTICS INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for KARYOPHARM THERAPEUTICS INC NOTE 6.000% 5/1, CUSIP 48576UAD8.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for KARYOPHARM THERAPEUTICS INC NOTE 6.000% 5/1, CUSIP 48576UAD8.